Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of vertebral metastatic tumor samples from pan-cancer primary tumors

ABSTRACT: RNA-seq of vertebral metastatic tumor samples from pan-cancer primary tumors

PROVIDER: PRJNA1139803 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR29979849_1.fastq.gz	Fastqsanger.gz
	SRR29979849_2.fastq.gz	Fastqsanger.gz
	SRR29979850_1.fastq.gz	Fastqsanger.gz
	SRR29979850_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

RNA-seq of vertebral metastatic tumor samples from pan-cancer primary tumors II

Project description:RNA-seq of vertebral metastatic tumor samples from pan-cancer primary tumors II

| PRJNA1146422 | ENA

RNA-seq of vertebral metastatic tumor samples from pan-cancer primary tumors

Project description:To define the molecular underpinning of bone metastasis in pan-cancer, we performed high-throughput transcriptome sequencing (RNA-seq) using total RNA from veterbral metatases of LUAD, BRCA, PRAD, SCRA, LIHC, SKCM, THYM, etc. tissues. Afterwards, expression profile were used for further analysis.

2025-06-01 | GSE273023 | GEO

RNA-seq of vertebral metastatic tumor samples from pan-cancer primary tumors II

2025-06-01 | GSE274442 | GEO

Proteomic Profiling of Metastatic and Non-Metastatic Primary Tumors in Pancreatic Cancer

Project description:To investigate the molecular mechanisms of pancreatic cancer metastasis, we performed proteomic profiling on clinical samples from metastatic and non-metastatic primary tumors. This approach aims to identify key drivers of tumor progression.

2025-11-06 | PXD070396 |

Proteomics profiling in primary tumors of metastatic and non-metastatic breast cancers

Project description:Analysis of different proteomics profile in primary tumors of metastatic and non-metastatic breast cancers.

2023-03-09 | PXD037288 | Pride

INCLIVA-CC-Mass-Spectromety: Primary and metastatic colon cancer tumors

Project description:This dataset contains mass spectrometry raw data (.d and wiff files) of primary and metastatic tumors of 16 localized colon cancer patients

2025-07-07 | PXD061711 | Pride

Metabolic differences between primary and brain metastatic breast tumors revealed by in vivo [U-¹³C]-glucose infusion in mice

Project description:<p>Metastatic breast tumors must adapt to the metabolic constraints of their target tissues. To understand how tumor metabolism varies across sites, we compared glucose utilization in primary mammary fat pad (MFP) tumors and brain metastases derived from the breast cancer cell line MDA-MB-231. Tumors in each site displayed distinct patterns of metabolite labeling, reflecting differences in nutrient availability and biosynthetic activity. Brain tumors exhibited higher labeling of amino acids and TCA cycle intermediates, consistent with increased synthesis to overcome restricted nutrient access in the brain, whereas MFP tumors showed greater nucleotide synthesis activity. These findings illustrate how the tumor microenvironment shapes metabolic adaptation and highlight the flexible strategies cancer cells use to maintain growth in diverse tissues.</p>

2025-12-30 | MTBLS13152 | MetaboLights

Pan-Cancer Proteogenomic Characterization of Metastatic Brain Tumors

Project description:4D-DIA data Derived from Paired Primary Tumors, Brain Metastasis and Giloblastoma

2025-01-20 | PXD059751 |

Gene expression profiling of HNSCC cells derived from primary and matched metastatic tumors

Project description:To look at genes/pathways differentially expressed in metastatic and primary tumor cells we performed global gene expression profiling of the 3 sets of HNSCC lines derived from primary tumors and matched metastatic sites. Illumina HT-12 v4 BeadChip arrays were used. The data suggest that HNSCC lines derived from metastatic sites exhibit phenotypes distinct from those found in cells derived from the corresponding primary tumors. Metastatic cell lines upregulated several pathways involved in stem cell self-renewal, invasion and migration, which are well known characteristics of metastatic progression. We conclude that the cell lines derived from primary patient tumors and matched metastatic sites represent a reliable model to study HNSCC metastasis.

2018-07-27 | GSE117753 | GEO

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

Project description:To evaluate the efficacy and safety of nimotuzumab in the treatment of EGFR-amplified advanced pan solid tumors (Lung/Esophageal/Gastric/Pancreatic /Colorectal / Head and neck Cervical).

| 90799 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data